Oral PABA and vitiligo.
D010129:4-Aminobenzoic Acid / Q000009:adverse effects*; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D062365:Aminobenzoates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D014820:Vitiligo / Q000139:chemically induced*
D062365:Aminobenzoates; D010129:4-Aminobenzoic Acid